Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    24687088 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
Condition: Acute Myeloid Leukemia
Interventions: Drug: CPX-351;   Drug: Cytarabine;   Drug: Daunorubicin

Study has passed its completion date and status has not been verified in more than two years.